What's breaking now, across thousands of outlets.
(MedPage Today) -- The landmark oral RAS inhibitor daraxonrasib (Rasonque) showed efficacy in previously treated patients with metastatic RAS-mutant non-small cell lung cancer (NSCLC) in a phase I/II trial. Among 136 patients treated with daraxonrasib...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
WASHINGTON — The Pentagon is temporarily rescinding recently published clinical guidance for a new, mandatory testosterone deficiency screening policy for service members aged 30 and older, a U.S.
WASHINGTON — The Pentagon is temporarily rescinding recently published clinical guidance for a new, mandatory testosterone deficiency screening policy for service members aged 30 and older, a U.S.
This eBook brings together expert perspectives on several of the most pressing analytical topics facing today’s cell and gene therapy developers.
The Ig Nobel Prizes were awarded this week for humorous yet thought-provoking research. This year, the ceremony came with a twist.
As the stock price dips lower, this executive purchase shows confidence in the future of Surgery Partners.
You finish a workout feeling pleased with yourself. But an hour later, your legs feel heavy, climbing the stairs seems impossible and all you want to do is sit down.
